We suggest that further research utilizing human GBM specimens and in vivo, immunocompetent orthotopic GBM models will be necessary to assess the functional interplay between MTAP loss and the innate immune cells in GBM, and how they collectively influence the adaptive immune characteristics within the tumor. The gene discussed is MTAP; the disease is neoplasm.